Back
Oncolytics Biotech, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
ONCY
Oncolytics Biotech, Inc.
Last Price:
$1.00
Seasonality Move:
-1.52%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiOncolytics Biotech, Inc. Stock Forecast
-
Is Oncolytics Biotech, Inc. Stock Undervalued?The current Oncolytics Biotech, Inc. [ONCY] share price is $1.01. The Score for ONCY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
ONCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Oncolytics Biotech, Inc. Stock Go Up Next Year?
Data Unavailable
Oncolytics Biotech, Inc. Stock Rating
Data Unavailable
Oncolytics Biotech, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncolyticsbiotech.com
52-Week Data
52-Week High:
1.51
52-Week Low:
0.33
Prediction Charts
Market Cap:
108.7M
Price in USD:
1.01
Volume:
499K
Beta:
1.77
Technical Analysis
SMA50:
1.06
SMA100:
1.11
SMA200:
0.89
52-Wk Change:
13.82%
Stock Predictions
-
Is Oncolytics Biotech, Inc. stock public?Yes, Oncolytics Biotech, Inc. is a publicly traded company.
-
What is the Oncolytics Biotech, Inc. stock quote today?The Oncolytics Biotech, Inc. stock price is 1.01 USD today.
-
How to buy Oncolytics Biotech, Inc. stock online?You can buy Oncolytics Biotech, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 0.94 | 0.88 | 0.94 | 0.88 |
| Dec-3 | 0.88 | 0.91 | 0.93 | 0.88 |
| Dec-4 | 0.91 | 0.98 | 1.00 | 0.90 |
| Dec-5 | 0.98 | 0.99 | 1.01 | 0.95 |
| Dec-8 | 1.00 | 0.94 | 1.00 | 0.94 |
| Dec-9 | 0.95 | 0.98 | 0.99 | 0.94 |
| Dec-10 | 0.99 | 0.99 | 1.00 | 0.96 |
| Dec-11 | 0.99 | 1.00 | 1.00 | 0.96 |
| Dec-12 | 0.97 | 0.99 | 1.04 | 0.97 |
| Dec-15 | 1.02 | 0.92 | 1.02 | 0.92 |
| Dec-16 | 0.93 | 1.04 | 1.05 | 0.93 |
| Dec-17 | 1.04 | 1.01 | 1.06 | 0.99 |
| Dec-18 | 1.01 | 1.01 | 1.05 | 0.99 |
| Dec-19 | 1.02 | 1.01 | 1.03 | 0.98 |
Oncolytics Biotech, Inc. Earnings
Data Unavailable
Oncolytics Biotech, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.02 per share.
* Oncolytics Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.